<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02148835</url>
  </required_header>
  <id_info>
    <org_study_id>543-13</org_study_id>
    <nct_id>NCT02148835</nct_id>
  </id_info>
  <brief_title>Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals</brief_title>
  <official_title>Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clemens von Schacky</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Südbayerische Fleischwaren GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      New approaches to increase eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in our
      diet are needed, but any new approach needs to demonstrate the bioavailability of EPA+DHA,
      and its safety and palatability. The HS-Omega-3 Index is a prime parameter to demonstrate
      bioavailability in the long-term. Study hypothesis is that increased intake of EPA+DHA will
      increase the HS-Omega-3 Index. Study aim is to investigate how supplementing various sausages
      with omega-3 fatty acids influences the HS-Omega-3 Index in healthy volunteers, as compared
      to unsupplemented matching sausages. Safety and palatability of the sausages are also to be
      assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, placebo-controlled, mono-center comparison of two matching groups of sausages
      (active vs. control). The study will be conducted according to Good Clinical Practice.
      Randomization will be computer-generated by the sponsor. Sealed envelopes will be provided to
      the Investigator bearing individual randomization numbers, containing individual
      randomization results. Thus, in case of need, one sealed envelope can be opened to learn the
      randomization result of one patient without overall unblinding.

      Study participants will be requested to ingest approx. 80 g / day of the experimental
      sausages during the day at a time of their convenience. Study participants will be provided
      with the investigational product free of charge. If necessary, the investigational product
      will be shipped to study participants. Study participants will receive the exact amount of
      sausages to complete the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HS-Omega-3 Index at Baseline and End of Study</measure>
    <time_frame>baseline and 8 weeks</time_frame>
    <description>The HS-Omega-3 Index is the percentage of EPA+DHA in erythrocytes, as assessed with a highly standardized analytical procedure. Since the HS-Omega-3 Index correlates with tissue EPA+DHA, it represents an individual's status in EPA+DHA.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and Palatability of the Study Sausage</measure>
    <time_frame>10 weeks</time_frame>
    <description>Serious adverse events (SAE) not necessarily ending study participation are:
hospitalizations and surgical procedures
life-threatening events and accidents
Events leading to permanent damage to study participants,
Moreover, all other medical events will be recorded. All events qualifying as AE or SAE, according to Good Clinical Practice, will be recorded and reported to the ethic´s committee.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Triomeg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sausage: Triomeg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control sausage</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sausage: Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sausage: Triomeg</intervention_name>
    <description>Commercial sausages enriched with 330 - 510 mg EPA+DHA / 100 g Approximate average composition of active product per 80 g Sausage (Triomeg): 250 mg EPA+DHA as ethyl-ester Energy content 500 kJ (120 kcal), protein 12 g, Carbohydrates 0.8 g, total fat 9 g, of which 2.8 g saturated fatty acids, 4.5 g monounsaturates, 1.4 g polyunsaturates. sodium 0.66 g.</description>
    <arm_group_label>Triomeg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sausage: Control</intervention_name>
    <description>Control sausage: as active, but no EPA+DHA ethyl-ester.</description>
    <arm_group_label>Control sausage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects must be willing to eat 80 g of the sausage to be investigated per day.

          2. Age: 20 - 60 years

          3. Low HS-Omega-3 Index (&lt;5%)

          4. Subjects must have adequate fluency in German or English to complete baseline and
             follow-up interviews.

          5. Stable intake of food containing EPA+DHA before and during study

          6. Subjects must be able and willing to give written informed consent, and to comply with
             study procedures.

        Exclusion Criteria:

          1. Subjects for whom the intake of omega-3 fatty acids is mandatory according to recent
             treatment guidelines or who take omega-3 fatty acids supplements on a regular basis.

          2. Subjects consuming &gt;2 portions of fatty fish / week

          3. Subjects with serious bleeding disorder. Use of platelet inhibitors or conventional
             anticoagulation with a target INR of 2.0 - 3.0 is not an exclusion criterion.

          4. Subjects with any acute and life-threatening condition, such as collapse and shock,
             acute myocardial infarction (last three months), stroke, embolism.

          5. Subjects with significant medical co-morbidity, seriously limiting life expectancy or
             insulin-treated diabetes mellitus or a BMI&gt;30

          6. Allergy/intolerance or history of hypersensitivity to components of study
             intervention.

          7. Pregnant subjects and breastfeeding subjects. In addition, women of childbearing
             potential who will not practice a medically accepted method of contraception will be
             excluded.

          8. Subjects who, in the investigator's judgement, will not likely be able to comply with
             the study protocol or with known drug- or alcohol abuse/dependence in the past 2
             years.

          9. Use of any investigational agents within 30 days prior to t0
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anton Köhler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ludwig-Maximilians - University of Munich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Preventive Cardiology, Ludwig Maximilians-University Munich</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>May 23, 2014</study_first_submitted>
  <study_first_submitted_qc>May 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2014</study_first_posted>
  <results_first_submitted>July 12, 2017</results_first_submitted>
  <results_first_submitted_qc>November 29, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">September 24, 2018</results_first_posted>
  <last_update_submitted>November 29, 2017</last_update_submitted>
  <last_update_submitted_qc>November 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Clemens von Schacky</investigator_full_name>
    <investigator_title>Sponsor-Investigator</investigator_title>
  </responsible_party>
  <keyword>Omega-3 Index</keyword>
  <keyword>Bioavailability</keyword>
  <keyword>Eicosapentaenoic acid</keyword>
  <keyword>Docosahexaenoic acid</keyword>
  <keyword>Fortified food</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Triomeg</title>
          <description>Sausage: Triomeg
Sausage: Triomeg: Commercial sausages enriched with 330 - 510 mg EPA+DHA / 100 g Approximate average composition of active product per 80 g Sausage (Triomeg): 250 mg EPA+DHA as ethyl-ester Energy content 500 kJ (120 kcal), protein 12 g, Carbohydrates 0.8 g, total fat 9 g, of which 2.8 g saturated fatty acids, 4.5 g monounsaturates, 1.4 g polyunsaturates. sodium 0.66 g.</description>
        </group>
        <group group_id="P2">
          <title>Control Sausage</title>
          <description>Sausage: Control
Sausage: Control: Control sausage: as active, but no EPA+DHA ethyl-ester.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Triomeg</title>
          <description>Sausage: Triomeg
Sausage: Triomeg: Commercial sausages enriched with 330 - 510 mg EPA+DHA / 100 g Approximate average composition of active product per 80 g Sausage (Triomeg): 250 mg EPA+DHA as ethyl-ester Energy content 500 kJ (120 kcal), protein 12 g, Carbohydrates 0.8 g, total fat 9 g, of which 2.8 g saturated fatty acids, 4.5 g monounsaturates, 1.4 g polyunsaturates. sodium 0.66 g.</description>
        </group>
        <group group_id="B2">
          <title>Control Sausage</title>
          <description>Sausage: Control
Sausage: Control: Control sausage: as active, but no EPA+DHA ethyl-ester.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="22"/>
                <count group_id="B2" value="22"/>
                <count group_id="B3" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="22"/>
                <count group_id="B2" value="22"/>
                <count group_id="B3" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.4" spread="8.0"/>
                    <measurement group_id="B2" value="25.6" spread="4.1"/>
                    <measurement group_id="B3" value="26.0" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="22"/>
                <count group_id="B2" value="22"/>
                <count group_id="B3" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="0"/>
                <count group_id="B2" value="0"/>
                <count group_id="B3" value="0"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="22"/>
                <count group_id="B2" value="22"/>
                <count group_id="B3" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="22"/>
                <count group_id="B2" value="22"/>
                <count group_id="B3" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>HS-Omega-3 Index at Baseline and End of Study</title>
        <description>The HS-Omega-3 Index is the percentage of EPA+DHA in erythrocytes, as assessed with a highly standardized analytical procedure. Since the HS-Omega-3 Index correlates with tissue EPA+DHA, it represents an individual's status in EPA+DHA.</description>
        <time_frame>baseline and 8 weeks</time_frame>
        <population>As recruited.</population>
        <group_list>
          <group group_id="O1">
            <title>Triomeg</title>
            <description>Sausage: Triomeg
Sausage: Triomeg: Commercial sausages enriched with 330 - 510 mg EPA+DHA / 100 g Approximate average composition of active product per 80 g Sausage (Triomeg): 250 mg EPA+DHA as ethyl-ester Energy content 500 kJ (120 kcal), protein 12 g, Carbohydrates 0.8 g, total fat 9 g, of which 2.8 g saturated fatty acids, 4.5 g monounsaturates, 1.4 g polyunsaturates. sodium 0.66 g.</description>
          </group>
          <group group_id="O2">
            <title>Control Sausage</title>
            <description>Sausage: Control
Sausage: Control: Control sausage: as active, but no EPA+DHA ethyl-ester.</description>
          </group>
        </group_list>
        <measure>
          <title>HS-Omega-3 Index at Baseline and End of Study</title>
          <description>The HS-Omega-3 Index is the percentage of EPA+DHA in erythrocytes, as assessed with a highly standardized analytical procedure. Since the HS-Omega-3 Index correlates with tissue EPA+DHA, it represents an individual's status in EPA+DHA.</description>
          <population>As recruited.</population>
          <units>HS-Omega-3 Index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.18" spread="0.54"/>
                    <measurement group_id="O2" value="4.32" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.72" spread="0.66"/>
                    <measurement group_id="O2" value="4.50" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Safety and Palatability of the Study Sausage</title>
        <description>Serious adverse events (SAE) not necessarily ending study participation are:
hospitalizations and surgical procedures
life-threatening events and accidents
Events leading to permanent damage to study participants,
Moreover, all other medical events will be recorded. All events qualifying as AE or SAE, according to Good Clinical Practice, will be recorded and reported to the ethic´s committee.</description>
        <time_frame>10 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 Weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Triomeg</title>
          <description>Sausage: Triomeg
Sausage: Triomeg: Commercial sausages enriched with 330 - 510 mg EPA+DHA / 100 g Approximate average composition of active product per 80 g Sausage (Triomeg): 250 mg EPA+DHA as ethyl-ester Energy content 500 kJ (120 kcal), protein 12 g, Carbohydrates 0.8 g, total fat 9 g, of which 2.8 g saturated fatty acids, 4.5 g monounsaturates, 1.4 g polyunsaturates. sodium 0.66 g.</description>
        </group>
        <group group_id="E2">
          <title>Control Sausage</title>
          <description>Sausage: Control
Sausage: Control: Control sausage: as active, but no EPA+DHA ethyl-ester.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Minor adverse events</sub_title>
                <description>One participant had mild GI symptoms not related to the investigational product, considered not related to the investigational product.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Minor adverse event</sub_title>
                <description>One participant had a viral infection with fever, diarrhea and emesis, considered not related to the investigational product.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Minor adverse event</sub_title>
                <description>One participant had influenza, considered not related to the investigational product.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Minor adverse event</sub_title>
                <description>Three participants had mild symptoms of a cold, considered not related to the investigational product.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Dr. C. von Schacky</name_or_title>
      <organization>Preventive Cardiology, University of Munich</organization>
      <phone>+49 89 44005 2165</phone>
      <email>clemens.vonschacky@med.uni-muenchen.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

